TPA activates p21WAF-1 promoter in human T-cells through its second most upstream Sp1 site

Biochemical and Biophysical Research Communications

Volumn 304, Issue 4, 2003, Pages 696-700

  Schavinsky Khrapunsky, Y ^a   Huleihel, M ^a   Aboud, M ^a   Torgeman, A ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

CDK; CDK inhibitors; Cell cycle; Human T cells; Jurkat cells; p21WAF 1; PKC; Sp1; TPA; Transcription factors

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P21; PROTEIN SUBUNIT; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DNA BINDING PROTEIN; ENZYME INHIBITOR; PROTEIN KINASE; PROTEIN KINASE C; SP1 KINASE;

APOPTOSIS; ARTICLE; BINDING SITE; DRUG ANTAGONISM; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REGULATORY MECHANISM; T LYMPHOCYTE; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY; TRANSACTIVATION;

BINDING SITES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; ENZYME INHIBITORS; HUMANS; JURKAT CELLS; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; PROTEIN KINASES; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATION (GENETICS);

EID: 0037667595     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00650-8     Document Type: Article

References (41)

1. Zhang H., Xiong Y., Beach D. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell. 4:1993;897-906.
2. Macleod K., Sherry N., Hannon G., Beach D., Tokino T., Kinzler K., Vogelstein B., Jacks T. p53-dependent and independent expression of p21 during cell growth, differentiation and DNA damage. Genes Dev. 9:1995;935-944.
3. Namaba H., Hara T., Tukazaki T., Migita K., Ishikawa N., Ito K., Nagataki S., Yamashita S. Radiation-induced G1 arrest is selectively mediated by the p53-WAF1/Cip1 pathway in human thyroid cells. Cancer Res. 55:1995;2075-3080.
4. Zhang H., Hannon G., Beach D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1994;1750-1758.
5. LaBaer J., Garrett M.D., Stevenson L.F., Slingerland J.M. New functional activities of the p21 family of CDK inhibitors. Genes Dev. 11:1997;847-862.
6. Bellido T., O'brien C.A., Roberson P.K., Manolagas S.C. Transcriptional activation of the p21(WAF1/CIP1/CDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. J. Biol. Chem. 273:1998;21137-21144.
7. Hobeika A.C., Subramaniam P.S., Johnson H.M. IFNα induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells. Oncogene. 14:1997;1165-1170.
8. Li J.M., Datto M.B., Shen X., Hu Y., Wang X. Sp1, but not Sp3 functions to mediate promoter activation by TGF-β through canonical Sp1 binding sites. Nucleic Acids Res. 26:1998;2449-2456.
9. Billon N., van Grunsven L.A., Rudkin B.B. The CDK inhibitor p21WAF1/CIP1 is induced through p300-dependent mechanism during NGF-mediated neural differentiation of PC12 cells. Oncogene. 13:1996;2047-2054.
10. cip1 mediates the growth inhibitory effect of phorbol esters in human venous endothelial cells J. Biol. Chem. 272:1997;29967-29974.
11. Dempsey E.C., Newton A.C., Mochly-Rosen D., Fields A.P., Reyland M.E., Insel P.A., Messing R.O. Protein kinase C isozymes and the regulation of diverse cell responses. Am. J. Physiol. Lung Cell Mol. Physiol. 279:2000;L429-L438.
12. Biggs J.R., Kraft A.S. The role of the Smad3 protein in phorbol ester-induced promoter expression. J. Biol. Chem. 274:1999;36987-36994.
13. Gartel A.L., Tyner A.L. Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp. Cell Res. 246:1999;280-289.
14. Mellor H., Parker P.J. The extended protein kinase C superfamily. Biochem. J. 332:1998;281-292.
15. Ron D., Kazanietz M.G. New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J. 13:1999;1658-1676.
16. Lu Z., Liu D., Hornia A., Devonish W., Pagano M., Foster D.A. Activation of protein kinase C triggers its ubiquitination and degradation. Mol. Cell. Biol. 18:1998;839-845.
17. Isonishi S., Ohkawa K., Tanaka T., Howell S.B. Depletion of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances platinum drug sensitivity in human ovarian carcinoma cells. Br. J. Cancer. 82:2000;34-38.
18. Mor-Vaknin N., Torgeman A., Galron D., Lochelt M., Flugel R.M., Aboud M. The long terminal repeats of human immunodeficiency virus type-1 and human T-cell leukemia virus type-I are activated by 12-O-tetradecanoylphorbol-13-acetate through different pathways. Virology. 232:1997;337-344.
19. Torgeman A., Ben-Aroya Z., Grunspan A., Zelin E., Butovsky E., Hallak M., Lochelt M., Flugel R.M., Livneh E., Wolfson M., Kedar I., Aboud M. Activation of HTLV-I long terminal repeat by stress-inducing agents and protection of HTLV-I infected T-cells from apoptosis by the viral Tax protein. Exp. Cell Res. 271:2001;169-179.
20. Torgeman A., Mor-Vaknin N., Zelin E., Ben-Aroya Z., Lochelt M., Flugel R.M., Aboud M. Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetrade-canoylphorbol-13-acetate that is antagonized by protein kinase C. Virology. 281:2001;10-20.
21. Biggs J.R., Kudlow J.E., Kraft A.S. The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J. Biol. Chem. 271:1996;901-906.
22. Cip1/Waf1 by caspases is an early event during DNA damage-induced apoptosis J. Biol. Chem. 273:1998;19207-19212.
23. Waf1/Cip1 protects against p53-mediated apoptosis of human melanoma cells Oncogene. 14:1997;929-935.
24. Waf1/Cip1 against prostaglandin A2-mediated apoptosis of human colorectal carcinomam cells Mol. Cell. Biol. 16:1996;6654-6660.
25. Gorospe M., Wang X., Holbrook N.J. Functional role of p21 during cellular response to stress. Gene Expr. 7:1999;377-385.
26. Waf1 expression by UV light is mediated through mRNA stabilization and involves a vanadate-sensitive regulatory system Mol. Cell. Biol. 18:1998;1400-1407.
27. WAF1/CIP1 associated with cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells J. Biol. Chem. 275:2000;30256-30263.
28. Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis Oncogene. 18:1999;1131-1138.
29. WA-1/Cip1 Biochemistry. 41:2002;12771-12784.
30. WAF1/Cip1 gene by the p53 tumor suppressor protein J. Biol. Chem. 276:2001;29116-29125.
31. Lu S., Jenster G., Epner D.E. Androgen induction of cyclin-dependent kinase inhibitor p21 gene: role of androgen receptor and transcription factor Sp1 complex. Mol. Endocrinol. 14:2000;753-760.
32. WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members Proc. Natl. Acad. Sci. USA. 95:1998;6733-6738.
33. Eldar E., Zisman Y., Ullrich A., Livneh E. Overexpression of protein kinase C α-subtype in Swiss/3T3 fibroblasts causes loss of both high and low affinity receptor numbers for epidermal growth factor. J. Biol. Chem. 265:1990;13290-13296.
34. Livneh E., Shimon T., Bechor E., Doki Y., Schieren I., Weinstein I.B. Linking protein kinase C to cell cycle: ecotopic expression of PKC in NIH3T3 cells alters the expression of cyclins and Cdk inhibitors and induces adipogenesis. Oncogene. 12:1996;1545-1555.
35. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:1991;15771-15781.
36. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
37. WAF1/Cip1 gene by acting as a superactivator of the ubiquitous transcription factor Sp1 J. Biol. Chem. 274:1999;29572-29581.
38. Owen G.I., Richer J.K., Tung L., Takimoto G., Horwitz K.B. Progesterone regulates transcription of the p21WAF1 cyclin dependent kinase inhibitor gene through Sp1 and CBP/p300. J. Biol. Chem. 273:1998;10696-10701.
39. Pardali K., Kurisaki A., Moren A., ten Dijke P., Kardassis D., Moustakas A. Role of Smad proteins and transcription factor Sp1 in p21Waf1/Cip1 regulation by transforming growth factorβ J. Biol. Chem. 275:2000;29244-29256.
40. Torgeman A., Mor-Vaknin N., Aboud M. Sp1 is involved in protein kinase C independent activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate. Virology. 254:1999;279-287.
41. Franklin R.A., McCubrey J.A. Kinases: positive and negative regulators of apoptosis. Leukemia. 14:2000;2019-2034.